J.Jill CEO Coyne Receives 782.62 RSUs From $0.08 Dividend
Rhea-AI Filing Summary
Mary Ellen Coyne, CEO & President and a director of J.Jill, Inc. (JILL), reported changes in beneficial ownership on a Form 4 reflecting grant-related adjustments tied to the company dividend. On 10/01/2025 J.Jill paid a cash dividend of $0.08 per share to holders of common stock with record date 9/17/2025. Under the governing restricted stock unit agreements, Ms. Coyne received 782.62 additional restricted stock units as a result of the dividend; these units carry the same vesting and settlement terms as the underlying RSUs and were reported as an acquisition at $0. The filing also shows up to 71.15 performance stock units added (TSR PSUs) representing the maximum contingent shares eligible to vest under specified total shareholder return goals. Following these entries, Ms. Coyne beneficially owns 165,131.72 non-derivative shares equivalent and 15,011.61 derivative-equivalent shares as reported.
Positive
- $0.08 per-share dividend triggered 782.62 additional RSUs for the CEO under existing agreements
- Additional units retain original vesting and settlement terms, indicating no immediate acceleration of pay
Negative
- None.
Insights
Dividend reinvestment produced additional RSUs for the CEO; vesting conditions remain unchanged.
The Form 4 shows that the company’s $0.08 per-share cash dividend triggered the issuance of 782.62 additional restricted stock units to Ms. Coyne under existing RSU agreements.
These additional units are subject to the same vesting and settlement terms as the underlying grants, preserving the original performance and time-based conditions; this means the reporting reflects grant adjustments rather than new discretionary compensation.
Performance stock units disclosed are TSR-based and reported at maximum potential conversion.
The filing identifies up to 71.15 TSR PSUs representing the maximum number of common shares that could vest if absolute total shareholder return goals are met.
These are reported as contingent awards with no exercise price and will settle in common stock upon vesting, so they reflect potential future dilution contingent on achievement of specified goals.